Skip to main content

Table 6 Baseline predictors of NEI-VFQ 25 overall score after 6 months explored in multivariable regression analyses

From: Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population

Variable

Unadjusted effect

95% CI

P-value

Adjusted effect*

95% CI

P-value

Age

−0.24

−0.52,0.05

0.11

0.09

−0.18,0.36

0.52

Gender

0.41

−0.34,5.16

0.86

−2.54

−7.19,2.11

0.28

Marital status

−1.05

−2.59,0.48

0.24

−0.88

−2.34,0.59

0.24

LogMar best eye

−25.58

−33.02, −18.14

< 0.001

−10.40

−19.04,-1.74

0.02

LogMar treated eye

−6.87

−11.64,-2.10

0.005

−4.47

−8.99,0.06

0.05

EQ-5D score

18.01

8.41,27.61

< 0.001

7.98

0.68,15.27

0.03

NEI-VFQ 25 baseline

0.80

0.71,0.90

< 0.001

0.69

0.53,0.84

< 0.001

Treatment intensity

1.53

−3.07,0.01

0.05

−0.47

−2.29,1.35

0.61

PASS 5

−4.83

−7.46,- 2.21

< 0.001

0.15

−2.24,2.55

0.89

  1. *Adjusted for all variables in multiple regression analyses. Bold values = P < 0.001 and P < 0.05